| Revenue growth | 62.1% for Q4 FY26; 46.4% for full year FY26. |
|---|---|
| Margins | Gross margins in line; EBITDA impacted by seasonal brand mix. |
| Demand visibility | Strong rural recovery outpacing urban; quick commerce sustaining momentum. |
| Management confidence | Positive on long-term double-digit growth and margin expansion targets. |
Growth
Q4 revenue grew 62.1%; FY26 revenue up 46.4%. International business grew 31.4% like-for-like. Net profit declined 5.8% for the quarter.
Outlook
Management targets 17-18% EBITDA margins in next two years. FY27 tax rate projected at 25% (mix of cash/deferred).
Risks
Seasonal portfolio (Glucon-D, Nycil) impacted by delayed summer and rains. High finance costs from acquisition funding.
Earnings Call filed with BSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.
Zydus Wellness Ltd: key numbers
- Share price
- ₹520.60
- Market cap
- ₹16,563 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 88.0×Sector 43.4×
- Promoter holding
- 69.64%+0.01% QoQ
- FII holding
- 3.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Management Change
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has received an ESG score of 71.7 from SES ESG Research Pvt. Ltd., improving from the previous score of 70.
Zydus Wellness Annual General Meeting
Zydus Wellness Limited has filed the transcript of its 32nd Annual General Meeting held on August 4, 2026. This document records the proceedings of the meeting.
Zydus Wellness Earnings Call Transcript: Key Takeaways
Zydus reported 66.7% revenue growth, heavily distorted by the Complan (ComfortClick) acquisition. Organic performance was mixed as seasonal brands faced weather headwinds while personal care and international segments showed strong double-digit momentum.
Zydus Wellness Investor Presentation: Key Takeaways
Zydus Wellness Q1 FY27 earnings presentation highlights strong double-digit growth in core portfolios like Sugar Free and Everyuth, despite weather-related headwinds impacting seasonal brands like Glucon-D and Nycil.